• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, April 12, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mayo Clinic joins call for increased screening for HPV-related cancers

Bioengineer by Bioengineer
June 7, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ROCHESTER, Minn. – Mayo Clinic Cancer Center joined 69 other National Cancer Institute-designated cancer centers in calling for increased HPV vaccination and screening to eliminate HPV-related cancers. Participating centers issued a joint statement.

According to the statement, nearly 80 million Americans – 1 out of every 4 people – are infected with HPV, and more than 31,000 of these people will be diagnosed with an HPV-related cancer this year. Despite those statistics and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination rates remain low in the U.S.

"The HPV vaccine is a proven way to prevent certain types of cancer, but it's not being used widely enough," says Robert Diasio, M.D., director of the Mayo Clinic Cancer Center. "We want people to know this is an opportunity to prevent cancer and save lives."

Vaccination rates remain significantly lower than other recommended adolescent vaccines in the U.S. According 2016 data from the Centers for Disease Control (CDC), less than 50 percent of girls and 38 percent of boys completed the recommended vaccine series. Research shows there are numerous barriers to overcome to improve vaccination rates. Health care providers are not strongly recommending vaccination. Also, parents do not understand that this vaccine protects against several types of cancer, including cervical, anal, oropharyngeal (middle throat) and other genital cancers.

HPV experts from the nation's top cancer centers, along with partners from the National Cancer Institute, CDC and the American Cancer Society, are meeting June 7 – 8 in Salt Lake City to discuss a path forward to eliminating cancers caused by HPV, including reducing barriers to vaccination, as well as sharing education, training and intervention strategies to improve vaccination rates.

###

About Mayo Clinic Cancer Center

As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call the clinical trials referral office at 1-855-776-0015 (toll-free)

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. Learn more about Mayo Clinic. Visit the Mayo Clinic News Network.

Media Contact

Joe Dangor
[email protected]
507-284-5005
@MayoClinic

http://www.mayoclinic.org/news

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-joins-call-for-increased-screening-for-hpv-related-cancers/

Share12Tweet8Share2ShareShareShare2

Related Posts

Machine Learning Identifies Fall Risk in Parkinson’s

April 12, 2026

SGLT2 Inhibitors Safe, Effective for Diabetes in Elderly

April 12, 2026

PPARs’ Impact on Diabetic Kidney Disease Development

April 12, 2026

Medication Literacy Tool Developed for Older Chinese Patients

April 12, 2026
Please login to join discussion

POPULAR NEWS

  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    58 shares
    Share 23 Tweet 15
  • Boosting Breast Cancer Risk Prediction with Genetics

    47 shares
    Share 19 Tweet 12
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    45 shares
    Share 18 Tweet 11
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1012 shares
    Share 400 Tweet 250

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Bio-Based Sulfonated Cyclodextrin Catalyzes 5-HMF Synthesis

Eco-Friendly Geopolymer Bricks Boost Thermal Comfort

Prebiotic Xylooligosaccharides Improve Liver Disease via Gut

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 79 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.